Standard Biotools Inc. (LAB): Total Assets
$567.75M
As of 2025-12-31
$627.22M
As of 2026-06-30
+13.3%
3-year compound annual growth
+11.8%
5-year compound annual growth
+4.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $567.75M | -7.3% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $612.35M | +89.5% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $323.07M | -17.2% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $390.31M | +41.8% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $275.21M | -15.3% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $324.76M | +22.6% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $264.81M | -12.8% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $303.65M | +5.7% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $287.35M | -6.2% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $306.39M | -17.2% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $370.05M | -9.2% | 2017-03-03, Balance as of period end |
| 2014-12-31 | $407.56M | +248.6% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $116.92M | +2.8% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $113.73M | +43.4% | 2014-03-12, Balance as of period end |
| 2011-12-31 | $79.33M | +219.9% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $24.80M | n/a | 2012-03-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Standard Biotools Inc. (LAB) | 2025-12-31 | $567.75M | -7.3% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $327.65M | -6.7% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $688.13M | +2.8% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $1.42B | +1.6% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $271.15M | -21.2% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $323.15M | +0.4% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $92.11M | +21.0% |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $219.47M | -10.2% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
Compare LAB, SPRY, NRIX, CYTK side by side · Screen every company in Pharmaceutical Preparations ↗